The European Society of Endocrinology Meets With European Parliament Members to Discuss Limiting the Socioeconomic Impact of Osteoporosis in Europe
MILAN, October 18, 2018 /PRNewswire/ --
In Brussels, the European Society of Endocrinology has met 10 European Parliament members and proposed a shared agenda to limit the socioeconomic impact of Osteoporosis in Europe.
Tackling hypovitaminosis D, early diagnosis of vertebral fractures, access and adherence to therapies are the key points to work on.
Affecting more than half of population aged over 80, osteoporosis represents an emergency in terms of social relevance and economic - healthcare costs. The European Society of Endocrinology seizes the opportunity of the World Osteoporosis Day to meet European Authorities andset forth a proposal of shared healthcare policies that may produce large-scale benefits and improve people's health and State budgets.
"Fragility fractures have an important economic impact. The direct costs (hospitalizations) only in Italy account for around 9 billion euros. 1 more billion of indirect costs, such as rehabilitation costs and losses due to absence from work, has to be added. We find the same situation in the rest of EU Statesas well - says Prof. Andrea Giustina, Professor of Endocrinologyat San Raffaele Hospital in Milanand President-Electof the European Society of Endocrinology - The three-point document we will set forth to the EP members proposes some cost-effective measures of clinical practice aimed at limiting costs and drastically reducingthe incidence of this disease."
The document prepared by the ESE is set out in 3 points:
Tackling hypovitaminosis D: most European people (mainly in Southern Europe) show vitamin D deficiency, the hormone synthetized by human skin through sunlight exposure which is essential to bone mineralization. When a vitamin D deficiency is shown, a cholecalciferol supplementation is required.
Early diagnosis of vertebral fractures: often underrated, and characterized by non-specific or absent painful symptoms, and therefore late-diagnosed, vertebral fractures represent an important risk factor for further vertebral column and femur fractures. Beside primary and secondary prevention it's essential to promote an education to tertiary prevention and timely diagnostics in which the morphometric identification in carriers of vertebral fractures becomes the key point for a policy aimed at the reduction of poly-fracture events as well as the increase of direct and indirect costs.
Access and adherence to therapies: recent studies have shown that more than 50% of women with osteoporosis do not start the anti-osteoporotic pharmacologic treatment, and that only a small percentage of those who undergo such treatment continue the treatment for more than 1 year. According to the ESE, it is essential to start information policies for doctors and population in general in order to help the proper access to treatments and the adherence to therapies.
"European endocrinologists wish that this agenda of intervention might gain the widest consent among Institutions and are ready to help in order to find in practice the most effective instruments to implement intervention on the mentioned criticalities. They also commit themselves to verify the execution and effectiveness of said instruments 12 months hence," concludes Giustina.
Celltrion partners with TV star Mollie Pearce to launch the second installation of the Where's Crohn's & Colitis (CC)? campaign for this year's World IBD Day (19 May 2024).
The campaign focuses on access to IBD care and treatment as the burden of...
On Wednesday, May 15, Red Door Community hosted their annual Celebrating Women Working and Living with Cancer Luncheon at the Metropolitan Club in New York City. The event raised more than $300,000 while shining a light on the women who inspire us...
Product: Kalihim (Philippine Bread Roll)
Issue: Food - Allergen - Egg
Distribution: British Columbia
See the affected products and product photos for this recall
SOURCE Canadian Food Inspection Agency (CFIA)
The global industrial automation market in life sciences industry size is estimated to grow by USD 5.06 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 11.4% during the forecast period. ...
Boston Scientific Corporation today announced positive six-month results from the ongoing pivotal MODULAR ATP clinical trial of the mCRMtm System,* the first modular cardiac rhythm management (CRM) system that consists of the EMBLEMtm Subcutaneous...
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...